Brain Structural Effects of Antidepressant Treatment in Major Depression
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Depressive disorder is a very frequent and heterogeneous syndrome. Structural imaging techniques offer a useful tool in the comprehension of neurobiological alterations that concern depressive disorder. Altered brain structures in depressive disorder have been particularly located in the prefrontal cortex (medial prefrontal cortex and orbitofrontal cortex, OFC) and medial temporal cortex areas (hippocampus). These brain areas belong to a structural and functional network related to cognitive and emotional processes putatively implicated in depressive symptoms. These volumetric alterations may also represent biological predictors of response to pharmacological treatment. In this context, major findings of magnetic resonance (MR) imaging, in relation to treatment response in depressive disorder, will here be presented and discussed. Keywords: amitriptyline, amygdala, cingulate, citalopram, doxepine, fluoxetine, fluxovamine, hippocampus, mirtazapine, paroxetine, prefrontal cortex, reboxetine, sertraline, trimipramine, venlafaxine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hankin, B. L., Abramson, L. Y., Moffitt, T. E., Silva, P. A., McGee, R., & Angell, K. E. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.1.128 · Cited by 2,333 · cited 2×
“This may indicate a modulatory response effect influenced by gender [67, 130].”
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590 · cited 1×
“Magnetic resonance imaging (MRI) studies on depressive disorder have shown volume reductions in frontal regions, hippocampus, putamen and caudate nucleus [15-18], anterior cingulate [19], amygdala [20], as well as white matter hyperintense lesions [21].”
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Furthermore, clinical outcome of patients with depressive disorder can be fairly variable and prediction of treatment response is a challenge for development of reliable therapies [113].”
Sheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 3×
“Indeed, a smaller hippocampal volume has been associated with severity of depression [114, 115], early onset [116-118], refractory illness [70, 114, 119, 120], longer duration of untreated depression [121], comorbidity with childhood abuse [122] and high levels of disease burden [72, 123-125] or anxiety [126, 127].”
Lower Hippocampal Volume in Patients Suffering From Depression: A Meta-Analysis
Campbell, S., Marriott, M., Nahmias, C., & MacQueen, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.598 · Cited by 1,156
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980 · cited 1×
“Indeed, a smaller hippocampal volume has been associated with severity of depression [114, 115], early onset [116-118], refractory illness [70, 114, 119, 120], longer duration of untreated depression [121], comorbidity with childhood abuse [122] and high levels of disease burden [72, 123-125] or anxiety [126, 127].”
Koolschijn, P. C. M. P., van Haren, N. E. M., Lensvelt‐Mulders, G. J. L. M., Hulshoff Pol, H. E., & Kahn, R. S. (2009) · Human Brain Mapping · doi:10.1002/hbm.20801 · Cited by 902
Childhood trauma associated with smaller hippocampal volume in women with major depression
Vythilingam, M., Heim, C., Newport, J., Miller, A. H., Anderson, E., Bronen, R., Brummer, M., Staib, L., Vermetten, E., Charney, D. S., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2072 · Cited by 812 · cited 2×
“Indeed, a smaller hippocampal volume has been associated with severity of depression [114, 115], early onset [116-118], refractory illness [70, 114, 119, 120], longer duration of untreated depression [121], comorbidity with childhood abuse [122] and high levels of disease burden [72, 123-125] or anxiety [126, 127].”
McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0905 · Cited by 742
Cited by
Dionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78
Yang, Y., Zhu, D.-M., Zhang, C., Zhang, Y., Wang, C., Zhang, B., Zhao, W., Zhu, J., & Yu, Y. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00050 · Cited by 57
“In addition, since previous studies have indicated that antidepressant medication may affect brain structure and function in MDD (Dusi et al., 2015; Brakowski et al., 2017), we considered antidepressant types (SSRIs, SNRIs, and NaSSA) as a categorical variable and then repeated the ROI-based inter-group comparisons in…”
MethodKoenig, J., Westlund Schreiner, M., Klimes-Dougan, B., Ubani, B., Mueller, B. A., Lim, K. O., Kaess, M., & Cullen, K. R. (2018) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2018.08.013 · Cited by 37
How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
Artin, H., Zisook, S., & Ramanathan, D. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i6.201 · Cited by 33
Katsuki, A., Watanabe, K., Nguyen, L., Otsuka, Y., Igata, R., Ikenouchi, A., Kakeda, S., Korogi, Y., & Yoshimura, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093032 · Cited by 15
Metadata
- Authors
- Dusi, N., Barlati, S., Vita, A., & Brambilla, P.
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2015-08-31
- Volume
- 13
- Issue
- 4
- Pages
- 458-465
- ISSN
- 1570-159X (ISSN-L)
- OpenAlex
- W2407279452
- Cited by
- 131
- References
- 47
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain Structural Effects of Antidepressant Treatment in Major Depression. https://app.cochat.ai/papers/10.2174/1570159x1304150831121909
- The paper
- Dusi, N., Barlati, S., Vita, A., & Brambilla, P. (2015). Brain Structural Effects of Antidepressant Treatment in Major Depression. Current Neuropharmacology. https://doi.org/10.2174/1570159x1304150831121909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.